Related Experiment Video
Updated: Jun 30, 2026
11:58
Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
Published on: March 8, 2018
Gold nanoparticles conjugated to [Tyr3]octreotide peptide
P P Surujpaul1, C Gutiérrez-Wing, B Ocampo-García
1Instituto Nacional de Investigaciones Nucleares, Carretera México-Toluca S/N., La Marquesa, Ocoyoacac, Estado de México. C.P 52750, Mexico.
Biophysical Chemistry
|September 30, 2008
Summary
Researchers developed gold nanoparticles (AuNP) functionalized with [Tyr(3)]Octreotide (TOC) peptide for targeted neuroendocrine tumor imaging. The AuNP-TOC conjugate showed specific fluorescence in tumor tissues, enabling potential bioimaging applications.
Area of Science:
- Nanotechnology
- Biomedical Engineering
- Medical Imaging
Background:
- Neuroendocrine tumors (NETs) require advanced diagnostic tools.
- Targeted drug delivery and imaging agents are crucial for NET management.
- Gold nanoparticles (AuNP) offer unique optical properties for biomedical applications.
Purpose of the Study:
- To synthesize and characterize a multifunctional gold nanoparticle system capped with [Tyr(3)]Octreotide (TOC).
- To evaluate the potential of the AuNP-TOC conjugate for targeted bioimaging of neuroendocrine tumors.
Main Methods:
- Preparation and characterization of AuNP-TOC using transmission electron microscopy (TEM), UV-Vis, infrared, and fluorescence spectroscopy.
- Acquisition of fluorescence emission spectra in solution and in murine AR42J-tumor tissues.
- Analysis of fluorescence resonance shifts to determine tumor recognition.
Main Results:
- Successful functionalization of AuNP with TOC was confirmed through spectroscopic analysis.
- AuNP-TOC exhibited specific fluorescence recognition in neuroendocrine tumor tissues.
- A shift in fluorescence emission to 692 nm in tumor tissue indicated targeted binding, distinct from AuNP alone (684 nm).
Conclusions:
- The AuNP-TOC conjugate demonstrates specific targeting capabilities for neuroendocrine tumors.
- The observed near-infrared fluorescence emission at 692 nm suggests potential for AuNP-TOC in advanced bioimaging.
- This system holds promise for improved diagnostics and theranostics in neuroendocrine oncology.
